テリックスと日本メジフィジックスが 日本における腎癌イメージング剤に関して パートナーシップの基本合意書を締結
15 août 2018 19h00 HE
|
Telix Pharmaceuticals Limited; Nihon Medi-Physics Co., Ltd.
MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（本社：オーストラリア メルボルン、CEO：Dr. Christian...
First Patient Imaged in Prostate Imaging Study
12 août 2018 18h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
テリックス･ファーマシューティカルズとjfe、日本の製造パートナーシップを進める
25 juil. 2018 19h00 HE
|
Telix Pharmaceuticals Limited
メルボルン , July 26, 2018 (GLOBE NEWSWIRE) -- および京都発 (グローブニューズワイヤ) -- 標的放射性医薬品または「分子標的放射線」 (MTR) ベースの診断用･治療用製品の開発に注力するオーストラリアのバイオ製薬会社であるテリックス･ファーマシューティカルズ (Telix Pharmaceuticals Limited、ASX:TLX)...
Telix Pharmaceuticals and JFE Progress Japanese Manufacturing Partnership
25 juil. 2018 19h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and TOKYO, July 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development...
Telix and Isologic conclude manufacturing agreement for North America
25 juin 2018 06h47 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and MONTREAL, June 25, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix Group”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
Science and Industry Endowment Fund Grant Awarded for Advanced Biologics Manufacturing
17 juin 2018 20h06 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, June 18, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
テリックス･ファーマシューティカルズと大阪大学、アルファ核種の研究で科学技術振興機構の資金を取得
30 mai 2018 06h40 HE
|
Telix Pharmaceuticals Limited
京都および大阪発, May 30, 2018 (GLOBE NEWSWIRE) -- 標的放射性医薬品または「分子標的放射線」 (MTR) ベースの診断用･治療用製品の開発に注目するオーストラリアのバイオ製薬会社であるテリックス･ファーマシューティカルズ (Telix Pharmaceuticals Limited、ASX.TLX、以下「テリックス」または「同社」)...
Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research
29 mai 2018 19h00 HE
|
Telix Pharmaceuticals Limited
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership
15 avr. 2018 20h15 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and NANTES, France, April 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on...
Drug Master File for Prostate Imaging Product Filed with the FDA
26 mars 2018 08h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on...